Fitbit's value isn't just in its wearables. It's in its data and cloud connectivity. Fitbit's had a good run with its line of functional, stylish activity trackers and health monitors. Customers can choose between classic trackers, a few smart watches, and even smart headphones and weight scales - with a large selection of accessories to mix and match...
The price here has focused into the obvious descending triangle for almost about a year now! It is not obvious if it will hold or not, but the current company health especially regarding profitability along with price action point towards a downward move, especially after the bullish momentum over the last couple of days. This play is being taken to play on the...
This stock has been one of the best winners in healthcare over the past few years, in terms of company health, profitability and correlation to stock price action. All the same, just like with A , the current market uncertainty has left the stock here in a wedge pattern after its earnings report. Even though the earnings beat estimates, it was not better than the...
I don't follow this stock and it was a friend of mine who pointed it out to me. There is a massive amount of pain in this stock chart. First off, you had a bad, bad break of the 200 day moving average all the way back on January 23rd. If you were watching the charts, this should have been a pretty good signal that something was up with the stock. You also...
Found myself looking around for some side plays with the stock markets rallying today all while cryptos are facing some uncertainty. I'm also keeping my fingers crossed for UofL to sign Chris Mack as their head men's basketball coach. Anywho lets get into it TRXC TransEnterix is a small healthcare instrument supply company, the fundamentals are not great but its...
My opinion of where TROV is headed in the next few days. I'm a swing trader so I dont hold em' for longer than a 2 weeks. I'm open to ideas and suggestions as I am still learning the trade myself.
This needs volume to fill the gap. Not Much news out. Think or swim Calendar says ER is the 15th of March Meeting with investors is on the 18th, saw a decent Roth Conference Slideshow, and they just had an inducement grant approved and I believe there was insider stock purchase a month or two ago. The company will meet with investors throughout the day on Tuesday,...
FDA Grants INSYS Therapeutics ‘Fast Track’ Designation for Cannabidiol (CBD) Oral Solution as INSYS Therapeutics, Inc. (NASDAQ:INSY), announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the company’s cannabidiol (CBD) oral solution for the treatment of Prader-Willi syndrome, a rare and complex genetic disorder...
Gilead's core product pipeline, including recent FDA approval is set to soar as key drugs and generics are continuing to outperform. The company's recent acquisition of KITE Pharma came at the perfect moment with KITE being granted a key drug approval by the FDA. Gilead's recent cost cutting efforts and R&D focus are to further push growth prospect and boost...
Jaguar Health announced Friday a stock split, issuing 21 & 1/4 million shares @ .20/ea. Entry for October. 2 is long, going active Tuesday with an additional $4.25 million being further issued. I have a 50% target.
The stock is moving in a sideways parallel channel started at the beginning of 2017. This movement can be a redistribution or an accumulation phase, it depends if it breaks lower or higher. If the price breaks lower the minimum target is around 70 and if it breaks higher the minimum target is around 88. The breakout must be confirmed by very high volume to avoid...
This company is going places, I have been researching the team, the fundamentals, and TA for about a week or two for a few hours every day. The entirety of the staff checks out and they have built a HIPPA approved platform to interface with EMR companies. This will revolutionize healthcare as we know it, they have a free app coming out this month for patients to...
CLLS hit its support levels recently, while holding firmly. This may be a great setup for another bull run in 2nd best running sector - healthcare.
Went long $65C before the test and break of $64.50 which broke on strong volume with a push to 64.59HOD. Also there was huge call sweep in June 55 and 56Calls Usually means News, Upgrades etc on the bullish upside! -TheTradingNinja
Attached is a piece about SWKH in which I discuss the value within the company, and I suggest it as a way of exposure to the healthcare technology sector without the risk. How is that possible? SWKH uses debt investments when making acquisitions in companies. Debt investments are usually the first investments to be paid back in full when a company undergoes...